SMS PHARMACEUTICALS
Back to Balance Sheet
|
SMS PHARMACEUTICALS Last 5 Year Net Current Assets History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Current Assets (Including Current Investments) | ₹202 Cr | ₹156 Cr | ₹181 Cr | ₹114 Cr | ₹74 Cr |
What is the latest Net Current Assets ratio of SMS PHARMACEUTICALS ?
Year | Net Current Assets |
---|---|
Mar2024 | ₹202 Cr |
Mar2023 | ₹156 Cr |
Mar2022 | ₹181 Cr |
Mar2021 | ₹114 Cr |
Mar2020 | ₹74 Cr |
How is Net Current Assets of SMS PHARMACEUTICALS Trending?
Years | Net Current Assets | % Change | |
---|---|---|---|
Mar2024 | ₹202 Cr | 29.82 | |
Mar2023 | ₹156 Cr | -13.75 | |
Mar2022 | ₹181 Cr | 58.53 | |
Mar2021 | ₹114 Cr | 54.81 | |
Mar2020 | ₹74 Cr | - |
Compare Net Current Assets of peers of SMS PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SMS PHARMACEUTICALS | ₹1,737.6 Cr | 2.1% | -16.9% | 53.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹423,974.0 Cr | 1.3% | -4.7% | 22.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹161,729.0 Cr | 6.3% | 3.3% | 59.2% | Stock Analytics | |
CIPLA | ₹116,999.0 Cr | -0.7% | -3.3% | 2.1% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹101,771.0 Cr | 2.1% | -9.7% | -0.3% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹97,951.9 Cr | 2.1% | -2.8% | 26.4% | Stock Analytics |
SMS PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SMS PHARMACEUTICALS | 2.1% |
-16.9% |
53.2% |
SENSEX | 2.7% |
0.8% |
9.7% |
You may also like the below Video Courses